Related content

ERCC1 and XRCC1 expression predicts survival in bladder cancer patients receiving combined trimodality therapy

By Sakano   Ogawa   Yamamoto   Nishijima   Miyachika   Matsumoto   Hara   Matsuyama  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 403-410

Spandidos Publications

Access to resources Recommend Favorite

Clinical efficacy of CyberKnife combined with chemotherapy and hyperthermia for advanced nonsmall cell lung cancer

By Wang  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 527-530

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of 5fluorouracil, leucovorin and bevacizumab in combination with radiation therapy in patients with locally advanced rectal cancer

By Inoue   Okigami   Kawamoto   Okugawa   Hiro   Saigusa   Toiyama   Tanaka   Mohri   Kusunoki  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 511-516

Spandidos Publications

Access to resources Recommend Favorite

Survivin, Ki67 and tumor grade as predictors of response to docetaxelbased neoadjuvant chemotherapy in locally advanced breast cancer

By              

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 839-844

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 405-410

Spandidos Publications

Access to resources Recommend Favorite